Nektar Therapeutics
NKTR
#4560
Rank
NZ$3.77 B
Marketcap
NZ$131.55
Share price
5.23%
Change (1 day)
636.94%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): NZ-$7.17

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is NZ-$7.35. In 2024 the company made an earnings per share (EPS) of NZ-$6.08 an increase over its 2023 EPS that were of NZ-$38.05.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$7.1717.84%
2024NZ-$6.08-84.02%
2023NZ-$38.05-25.89%
2022NZ-$51.35-31.12%
2021NZ-$74.5414.86%
2020NZ-$64.90-1.19%
2019NZ-$65.68-163.96%
2018NZ$102.69-725.4%
2017NZ-$16.42-42.73%
2016NZ-$28.6783.33%
2015NZ-$15.6439.53%
2014NZ-$11.21-69.29%
2013NZ-$36.49-6.67%
2012NZ-$39.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.35-363.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$2.36-132.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$24.90-438.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ-$3.21-56.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.70-272.82%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$10.30-240.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
NZ$0.12-101.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
NZ$3.60-148.94%๐Ÿ‡ฎ๐Ÿ‡ช Ireland